Identification of a novel hypoglycemic small molecule, trans-2, 4-dimethoxystilbene by rectifying gut microbiota and activating hepatic AMPKα-PPARγ pathway through gut-liver axis
Zijing Wang(Qingdao University), Guifen Qiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Guanhua Du(Shanghai Jiao Tong University), Li Zhang(Target (United States)), Ping He(Zhejiang Chinese Medical University), Chunyang Xu(Capital Medical University), Peng Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Tianshu Xu(Nanjing University of Chinese Medicine), Biyu Hou(Kunming Institute of Zoology), Xiuying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Tengfei Ji(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 1
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
SIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice
|Circulation Research|2011|183
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
|Biochemical Pharmacology|2020|160